This pro-tumoral CXCL10 feed-forward loop was also observed in breast cancer; albeit, CXCL10 also attracted more CD4+ and CD8+ lymphocytes to the TME, in a paracrine manner, which attenuated tumor progression [115]. Here, CD8A is linked to breast carcinoma.